cDNA sequence of human apolipoprotein(a) is homologous to plasminogen

McLean, John W., Tomlinson, James E., Kuang, Wun-Jing, Eaton, Dan L., Chen, Ellson Y., Fless, Gunther M., Scanu, Angelo M., Lawn, Richard M.·1987·Nature

Cited by (1,002)

Items 901–1,000 of 1,002

  1. LIPOPROTEIN (a) AND CORONARY HEART DISEASE IN FAMILIAL HYPERCHOLESTEROLAEMIA
    Richard S. Houlston, Jeremy Quiney, J N Mount · 1988 · The Lancet
  2. Transgenic mice expressing a human apolipoprotein[a] allele
    Francesco Acquati, Robert E. Hammer, Barbara Ercoli et al. · 1999 · Journal of Lipid Research
  3. Specific anionic residues of the recombinant kringle 2 domain of tissue-type plasminogen activator that are responsible for stabilization of its interaction with .omega.-amino acid ligands
    Vesna Sator de Serrano, Francis Castellino · 1993 · Biochemistry
  4. An Apolipoprotein(a) Peptide Delays Chylomicron Remnant Clearance and Increases Plasma Remnant Lipoproteins and Atherosclerosis In Vivo
    Cecilia M. Devlin, Sung‐Joon Lee, George Kuriakose et al. · 2005 · Arteriosclerosis Thrombosis and Vascular Biology
  5. Insoluble complex formation of lipoprotein (a) with low density lipoprotein in the presence of calcium ions.
    Akira Yashiro, Jessica C. O'Neil, H.F. Hoff · 1993 · Journal of Biological Chemistry
  6. The role of lipoprotein(a) in the vascular complications of diabetes mellitus
    Alicia Josephine Jenkins, James Donovan Best · 1995 · Journal of Internal Medicine
  7. Lipoprotein(a) levels in patients receiving renal replacement therapy: methodologic issues and clinical implications
    Daniel M. Levine, Bruce R. Gordon · 1995 · American Journal of Kidney Diseases
  8. Many roads lead to atheroma
    Michael R. Hayden, Michael A. Reidy · 1995 · Nature Medicine
  9. Proline-rich protein is a glycoprotein and an acute phase reactant
    Mikiko FUNAKOSHI, Jun Sasaki, Kikuo Arakawa · 1988 · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism
  10. Lipoprotein(a): A kinetic study of its influence on fibrin-dependent plasminogen activation by prourokinase or tissue plasminogen activator
    Jian Ning Liu, Peter C. Harpel, Ralph Pannell · 1993 · Biochemistry
  11. Structural Domains of Apolipoprotein(a) and Its Interaction with Apolipoprotein B-100 in the Lipoprotein(a) Particle
    Thierry Huby, Chantal Doucet, Hans Dieplinger, John Chapman, Joëlle Thillet · 1994 · Biochemistry
  12. Lipoprotein(a): Just an Innocent Bystander in Arterial Hypertension?
    Gabriele Brosolo, Andrea Da Porto, Stefano Marcante, Alessandro Picci, Filippo Capilupi, Patrizio Capilupi, Luca Bulfone, Antonio Vacca, Nicole Bertin, Cinzia Vivarelli et al. · 2023 · International Journal of Molecular Sciences
  13. Causal Relevance of Lp(a) for Coronary Heart Disease and Stroke Types in East Asian and European Ancestry Populations: A Mendelian Randomization Study
    Robert Clarke, Neil Wright, Kuang Lin, Canqing Yu, Robin G. Walters, Jun Lv, Michael Hill, Christiana Kartsonaki, Iona Y. Millwood, Derrick Bennett et al. · 2025 · Circulation
  14. Triglyceride Metabolism Modifies Lipoprotein(a) Plasma Concentration
    Maria Ramos-Cáceres, Itziar Lamíquiz-Moneo, Ana Cenarro, Pilar Calmarza, Victoria Marco-Benedí, Ana M. Bea, Rocío Mateo‐Gállego, José Puzo, José María Ordovás, Fernando Civeira et al. · 2022 · The Journal of Clinical Endocrinology & Metabolism
  15. Lipoprotein(a) and ultrasonographically determined early atherosclerotic changes in the carotid and femoral artery
    A. Šrámek, J.H.C. Reiber, Renée F. Baak-Pablo · 2003 · Journal of Thrombosis and Haemostasis
  16. Lipoprotein (a): a Unique Independent Risk Factor for Coronary Artery Disease
    Anjali Manocha, Lalit Mohan Srivastava · 2015 · Indian Journal of Clinical Biochemistry
  17. Variations of Lipoprotein(a) Levels in the Metabolic Syndrome: A Report from the Maracaibo City Metabolic Syndrome Prevalence Study
    Valmore Bermúdez, Joselyn Rojas, Juan Salazar et al. · 2013 · Journal of Diabetes Research
  18. An Increased Serum Level of Lipoprotein(a) Is a Predictor for Deep Vein Thrombosis in Patients with Spinal Cord Injuries
    Chao-Wei Wang, Linlin Su, Sheng-Bo Tao · 2015 · World Neurosurgery
  19. Elevated lipoprotein (a) levels are an independent risk factor for retinal vein occlusion
    Claudia Kuhli‐Hattenbach, Wolfgang Miesbach, Marc Lüchtenberg, Thomas Kohnen, Claudia Kuhli-Hattenbach · 2016 · Acta Ophthalmologica
  20. The oxidized phospholipids linked to human apolipoprotein(a) do not derive from circulating low‐density lipoproteins and are probably of cellular origin
    Celina Edelstein, Binu B. Philips, Ditta Pfaffinger · 2008 · The FASEB Journal
  21. Relationship between lipoprotein(a) concentrations and intima-media thickness: a healthy population study
    Pilar Calmarza, JM Trejo, Carlos Lapresta, Pilar López · 2011 · European Journal of Preventive Cardiology
  22. Urinary apo(a) discriminates coronary artery disease patients from controls
    Karam Kostner, Kurt Huber, Thomas Stefenelli, Heinrich Rinner, Gerald Maurer · 1997 · Atherosclerosis
  23. Detection of short repeated genomic sequences on metaphase chromosomes using padlock probes and target primed rolling circle DNA synthesis
    Jakob S Lohmann, Magnus Stougaard, Jørn Koch · 2007 · BMC Molecular Biology
  24. Lipoprotein(a) levels in relation to albumin concentration in childhood nephrotic syndrome
    Davide Noto, Carlo Maria Barbagallo, Armida Lo Cascio et al. · 1999 · Kidney International
  25. Development of Antibody Against Epitope of Lipoprotein(a) Modified by Oxidation
    Shingo Yamada, Ryuichi Morishita, Shigefumi Nakamura, Toshio Ogihara, Yoshiaki Kusumi, Isamu Sakurai, Nobuhiko Kubo, Ikunosuke Sakurabayashi · 2000 · Circulation
  26. Gender-specific nonrandom association between the α1-antichymotrypsin and apolipoprotein E polymorphisms in the general population and its implication for the risk of Alzheimer's disease
    M. Ilyas Kamboh, Dharambir K. Sanghera, Christopher E. Aston, Clareann H. Bunker, Richard F. Hamman, Robert E. Ferrell, Steven Trent DeKosky · 1997 · Genetic Epidemiology
  27. Molecular basis of an apolipoprotein[a] null allele: a splice sitemutation is associated with deletion of a single exon
    Laura A. Cox, Catherine Jett, James E. Hixson · 1998 · Journal of Lipid Research
  28. Definition of the transcription initiation site of human plasminogen gene in liver and non hepatic cell lines
    Nicoletta Malgaretti, Ludovica Bruno, Marco Pontoglio · 1990 · Biochemical and Biophysical Research Communications
  29. Evolutionary origin of numerous kringles in human and simian apolipoprotein(a)
    Kazuho Ikeo, Kei Takahashi, Takashi Gojobori · 1991 · FEBS Letters
  30. Effect of simvastatin on plasma lipids, apolipoproteins and lipoprotein particles in patients with primary hypercholesterolaemia
    Jean‐Marie Bard, G. Luc, Ph. DOUSTE‐BLAZY, Pierre Drouin, Olivier Ziegler, Bernard JACOTOT, C. Dachet, Jean Luc De Gennes, Jean‐Charles Fruchart · 1989 · European Journal of Clinical Pharmacology
  31. Lipoprotein(a) Levels and Isoforms and Fibrinolytic Activity in Postmenopause – Influence of Hormone Replacement Therapy
    Antonio Cano, Cristina Falcó, Francisco España · 1999 · Thrombosis and Haemostasis
  32. Molecular evolution of serine protease and its inhibitor with special reference to domain evolution
    Takashi Gojobori, Kazuho Ikeo · 1994 · Philosophical Transactions of the Royal Society B Biological Sciences
  33. The cationic locus on the recombinant kringle 2 domain of tissue-type plasminogen activator that stabilizes its interaction with .omega.-amino acids
    Vesna Sator de Serrano, Francis J. Castellino · 1992 · Biochemistry
  34. Alteration of lipoprotein(a) concentration with glycemic control in non-insulin-dependent diabetic subjects without diabetic complications
    Hiroshi Nakata, Kazutoshi Horita, Masaaki Eto · 1993 · Metabolism
  35. Lp(a) Lipoprotein: A Monogenic Risk Factor for Cardiovascular Disease
    Kåre Berg · 1994 · Developments in cardiovascular medicine
  36. Relook at lipoprotein (A): Independent risk factor of coronary artery disease in North Indian population
    Jamal Yusuf, Neeraj Kumar Yadav, Saibal Mukhopadhyay, Abhishek Goyal, Vimal Mehta, Vijay Kumar Trehan, Sanjay Tyagi · 2014 · Indian Heart Journal
  37. Differential expression of oxidized/native lipoprotein(a) and plasminogen in human carotid and cerebral artery plaques
    Takahiko Umahara, Toshiki Uchihara, Shingo Yamada, Takao Hashimoto, Jiro Akimoto, Jo Haraoka, Toshihiko Iwamoto · 2011 · Atherosclerosis
  38. Lipoprotein (a)
    Paul N. Durrington, Jonathan D. Schofield, Tarza Jamal Siahmansur, Handrean Soran · 2014 · Current Opinion in Lipidology
  39. Acute myocardial infarction in a young man
    Robert L. Duerr, Robert S. Ross · 1993 · Trends in Cardiovascular Medicine
  40. Therapeutic Vaccines for Hypertension and Dyslipidemia
    Hironori Nakagami, Hiroshi Koriyama, Ryuichi Morishita · 2014 · International Heart Journal
  41. Association of Lp-PLA2 activity with allele-specific Lp(a) levels in a bi-ethnic population
    Byambaa Enkhmaa, Erdembileg Anuurad, Wei Zhang · 2010 · Atherosclerosis
  42. Lipoprotein(a) is increased in triglyceride-rich lipoproteins in men with coronary heart disease, but does not change acutely following oral fat ingestion
    Fritz Hoppichler, H.G. Kraft, Christoph Sandholzer, Monika Lechleitner, Josef R. Patsch, Gerd Utermann · 1996 · Atherosclerosis
  43. Elevated lipoprotein(a) levels in patients with acute myeloblastic leukaemia decrease after successful chemotherapeutic treatment
    Axel Niendorf, A. Stange, Ulrike Beisiegel† · 1992 · Journal of Molecular Medicine
  44. Lipoprotein (a), haemostatic variables and cardiovascular damage in hypertensive patients
    Leonardo Alberto Sechi, Cristiana Catena, Daniele Casaccio · 2000 · Journal of Hypertension
  45. Apo(a) promotes thrombosis in a vascular injury model by a mechanism independent of plasminogen
    Jingfeng Sha, B. MCCULLOUGH, Erika Hart · 2005 · Journal of Thrombosis and Haemostasis
  46. Plasma Lipoprotein(a) Levels Are High in Patients with Central Retinal Artery Occlusion
    Masatoshi Murata, Tetsuo Saito, Shigeki Takahashi · 1998 · Thrombosis Research
  47. The binding of plasminogen fragments to cultured human umbilical vein endothelial cells
    Hua-Lin Wu, Ing-Shiang Wu, Ro-Yun Fang · 1992 · Biochemical and Biophysical Research Communications
  48. A Comparison of Structure and Thermal Behavior in Human Plasma Lipoprotein(a) and Low-Density Lipoprotein. Calorimetry and Small-Angle X-ray Scattering
    Ruth Prassl, Bernhard Schuster, Peter Michael Abuja, Monika Zechner, Gerhard Max Kostner, Peter Laggner · 1995 · Biochemistry
  49. Associations between classical cardiovascular risk factors and coronary artery disease in two countries at contrasting risk for myocardial infarction: the PRIME Study
    V. Graille, Jean Ferrières, A. Evans, Philippe Amouyel, Dominique Arveiler, G. Luc, Pierre Ducimetière · 2000 · International Journal of Cardiology
  50. Sib-pair analysis detects elevated Lp(a) levels and large variation of Lp(a) concentration in subjects with familial defective ApoB.
    Ytje Y. van der Hoek, Arno Lingenhel, H.G. Kraft, Joep C. Defesche, John J.P. Kastelein, Gerd Utermann · 1997 · Journal of Clinical Investigation
  51. 6-Aminohexanoic Acid as a Chemical Chaperone for Apolipoprotein(a)
    Jin Wang, Ann L. White · 1999 · Journal of Biological Chemistry
  52. Analysis of the mechanism of lipoprotein(a) assembly
    Marlys L. Koschinsky, Santica M. Marcovina, Lorraine F. May · 1997 · Clinical Genetics
  53. Instability of lipoprotein(a) in plasma stored at -70 degrees C: effects of concentration, apolipoprotein(a) genotype, and donor cardiovascular disease.
    Josep M. Simó, Jordi Camps, Elisabet Vilella, F Gómez, Antonio Paul, Jorge Joven · 2001 · PubMed
  54. Effects of dietary fat saturation on plasma lipoprotein(a) and hepatic apolipoprotein(a) mRNA concentrations in cynomolgus monkeys
    Margaret E. Brousseau, José María Ordovás, Robert J. Nicolosi · 1994 · Atherosclerosis
  55. Short Introns Interrupting the Oct-2 POU Domain May Prevent Recombination between POU Family Genes without Interfering with Potential POU Domain ‘Shuffling’ in Evolution
    Koichi Matsuo, Oliver Clay, Patrik Künzler · 1994 · Biological Chemistry Hoppe-Seyler
  56. Plasminogen Activation on Tumor Cell Surface and its Involvement in Human Leukemia
    Hannele Tapiovaara, Riitta Alitalo, Antti Vaheri · 1996 · Advances in cancer research
  57. Hedgehog lipoprotein(a) is a modulator of activation of plasminogen at the fibrin surface. An in vitro study.
    Didier Rouy, P M Laplaud, Michel Saboureau · 1992 · Arteriosclerosis and Thrombosis A Journal of Vascular Biology
  58. Structure and Possible biological roles of Lp(a)
    Israel Karmansky, Nachman Gruener · 1994 · Clinical Biochemistry
  59. Association of lipoprotein(a) with atherothrombotic events and fibrinolytic variables. A case-control study
    Guido Franceschini, Elisabetta Cofrancesco, Omid Safa, Carla Boschetti, Elena Tremoli, L. Mussoni, Cesare R. Sirtori, Michele Cortellaro · 1995 · Thrombosis Research
  60. The Involvement of Lipoproteins in Atherogenesis Evolving Conceptsa
    Godfrey S. Getz · 1990 · Annals of the New York Academy of Sciences
  61. Prospective association of lipoprotein(a) concentrations and apo(a) size with coronary heart disease among men in the Multiple Risk Factor Intervention Trial
    Roger G. Evans, Ofer Shpilberg, B.Jessica Shaten, Shabnam Ali, M. Ilyas Kamboh, Lewis H. Kuller · 2001 · Journal of Clinical Epidemiology
  62. Vessel Wall-Related Risk Factors in Acute Vascular Events
    Lina Badimón, Juan J. Badimón, Marc C. Cohen · 1991 · Drugs
  63. Genetic Variation in Factor VII Associated with Variation in Plasma Lipoprotein(a) Concentration
    Robert Alexander Hegele, W. Carl Breckenridge, Jason Brunt, Philip W. Connelly · 1997 · Arteriosclerosis Thrombosis and Vascular Biology
  64. Hemostatic/Fibrinolytic Predictors of Allograft Coronary Artery Disease after Cardiac Transplantation
    Clyde R. Meckel, Todd J. Anderson, Gilbert H. Mudge · 1997 · Vascular Medicine
  65. Lipoprotein (a)
    Paul N. Durrington · 1995 · Baillière s Clinical Endocrinology and Metabolism
  66. Distribution of Serum Lipoprotein (a) Concentrations in a Healthy Turkish Population
    Asım Örem, Orhan Değer, Ekin Önder · 1994 · Annals of Clinical Biochemistry International Journal of Laboratory Medicine
  67. Apolipoprotein(a) isoform size influences binding of lipoprotein(a) to plasmin-modified des-AA-fibrinogen
    Casper B. Leerink, Pieter F.C.C.M. Duif, Nanda M. Verhoeven · 1994 · Fibrinolysis and Proteolysis
  68. Genetic determinants of atherosclerosis-related dyslipidemias and their clinical implications
    D. J. Galton · 1997 · Clinica Chimica Acta
  69. Three different LDL apheresis columns efficiently and equally reduce lipoprotein(a) concentrations in patients with familial hypercholesterolemia and small apolipoprotein(a) particles
    Anders Hovland, Santica M. Marcovina, Randolf I. Hardersen · 2011 · Transfusion and Apheresis Science
  70. A Chinese host genetic study discovered IFNs and causality of laboratory traits on COVID-19 severity
    Huanhuan Zhu, Fang Zheng, Linxuan Li, Yan Jin, Yuxue Luo, Zhen Li, Jingyu Zeng, Ling Fung Paul Tang, Zilong Li, Ningyu Xia et al. · 2021 · iScience
  71. Lipoprotein(a): a causal independent risk factor for coronary heart disease?
    Vilmundur G. Gudnason · 2009 · Current Opinion in Cardiology
  72. Inhibition of Pathologic Retinal Neovascularization by a Small Peptide Derived from Human Apolipoprotein(a)
    Hui Zhao, Huiyi Jin, Qian Li · 2009 · Investigative Ophthalmology & Visual Science
  73. Apolipoprotein(a) inhibits the conversion of Glu-plasminogen to Lys-plasminogen on the surface of vascular endothelial and smooth muscle cells
    Rocco Romagnuolo, Kristen DeMarco, Corey A. Scipione, Michael B. Boffa, Marlys L. Koschinsky · 2018 · Thrombosis Research
  74. Hypoascorbemia induces atherosclerosis and vascular deposition of lipoprotein(a) in transgenic mice.
    John Cha, Aleksandra Niedzwiecki, Matthias Rath · 2015 · Europe PMC (PubMed Central)
  75. Decreased binding of apolipoprotein (a) to familial defective apolipoprotein B-100 (Arg3500–>Gln). A study of the assembly of recombinant apolipoprotein (a) with mutant low density lipoproteins.
    Srdan Durovic, W Mrz, Saša Frank · 1994 · Journal of Biological Chemistry
  76. Serum Lipids, Lipoproteins and Apolipoproteins in Patients with Senile Dementia.
    Masaru Kuriyama, Youichi Hokezu, Seiji Togo, Kazuya Nagata, Kanehisa Takahashi, Takeshi Igakura, Mitsuhiro Osame · 1992 · Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics
  77. Euglobulin clot lysis induced by tissue type plasminogen activator in subjects with increased levels and different isoforms of lipoprotein (a)
    Justo Aznar, Amparo Estellés, Miguel Bretó · 1993 · Thrombosis Research
  78. Lipoprotein(a), friedewald formula, and NCEP guidelines
    Angelo M. Scanu · 2001 · The American Journal of Cardiology
  79. Standardization and Clinical Management of Lipoprotein(a) Measurements
    Giuseppe Lippi, Gian Cesare Guidi · 1998 · Clinical Chemistry and Laboratory Medicine (CCLM)
  80. Elevated levels of serum lipoprotein(a) and apolipoprotein(a) phenotype are not related to pre‐eclampsia
    Casper B. Leerink, Cynthia V. S. de Vries, Fiona R.M. van der Klis · 1997 · Acta Obstetricia Et Gynecologica Scandinavica
  81. [1] Apolipoproteins: Pathophysiology and clinical implications
    Wolfgang Patsch, Antonio M. Gotto · 1996 · Methods in enzymology on CD-ROM/Methods in enzymology
  82. Analysis of the aromatic 1H‐NMR spectrum of the kringle 5 domain from human plasminogen
    Theresa Thewes, Vasudevan Ramesh, Elena Simplaceanu · 1988 · European Journal of Biochemistry
  83. A Synthetic Peptide That Inhibits Lipoprotein(a) Assembly
    Rebecca J. Sharp, Matthew A. Perugini, Santica M. Marcovina, Sally P.A. McCormick · 2003 · Arteriosclerosis Thrombosis and Vascular Biology
  84. Effects of lipids on thrombotic mechanisms in atherosclerosis
    Dimitris Tousoulis, Graham Davies, John A. Ambrose, Costas A. Tentolouris, Christodoulos Stefanadis, Pavios Toutouzas · 2002 · International Journal of Cardiology
  85. Attenuation of immunologic reactivity of lipoprotein(a) by thiols and cysteine-containing compounds. Structural implications.
    Antonio Mario Scanu, D Pfaffinger, G M Fless · 1992 · Arteriosclerosis and Thrombosis A Journal of Vascular Biology
  86. Lp(a) lipoprotein in patients with arterial insufficiency of the lower extremities
    Örjan Norrgård, Karl‐Axel Ängquist, Gösta H. Dahlén · 1991 · European Journal of Vascular Surgery
  87. Gene expression of apolipoprotein(a) within the wall of human aorta and carotid arteries
    L Fu · 2001 · Atherosclerosis
  88. Reduction of lp(a) by different methods of plasma exchange
    I. Schenck, C. Keller, S. Hailer · 1988 · Journal of Molecular Medicine
  89. Kinetic analysis of lipoprotein (a) inhibition of plasminogen activation by tissue plasminogen activator in vitro
    Casper B. Leerink, J. A. Gimpel, Wouter Kortlandt · 1991 · Fibrinolysis and Proteolysis
  90. Biochemistry and Clinical Significance of Lipoprotein (a)
    Richard S. Houlston, W Friedl · 1988 · Annals of Clinical Biochemistry International Journal of Laboratory Medicine
  91. Lipoprotein (a)
    1991 · The Lancet
  92. Residual lipid risk in atherosclerotic cardiovascular disease
    Børge Grønne Nordestgaard, Robert Alexander Hegele · 2026 · European Heart Journal
  93. The rs10455872-G allele of the LPA gene is associated with high lipoprotein(a) levels and increased aortic valve calcium in a Mexican adult population
    Guillermo Celestino Cardoso-Saldaña, José Manuel Fragoso, Shamar L. M. Lale-Farjat, Margarita Torres‐Tamayo, Carlos Posadas‐Romero, Gilberto Vargas‐Alarcón, Rosalinda Posadas‐Sánchez · 2019 · Genetics and Molecular Biology
  94. Evidence and Uncertainties on Lipoprotein(a) as a Marker of Cardiovascular Health Risk in Children and Adolescents
    Simonetta Genovesi, Marco Giussani, Giulia Lieti, Antonina Orlando, Ilenia Patti, Gianfranco Parati · 2023 · Biomedicines
  95. Relationship Between Lipoprotein(a) and Angiographic Severity of Femoropopliteal Lesions
    Koji Yanaka, Hirokuni Akahori, Takahiro Imanaka, Kojiro Miki, Nagataka Yoshihara, Toshio Kimura, Takamasa Tanaka, Masanori Asakura, Masaharu Ishihara · 2020 · Journal of Atherosclerosis and Thrombosis
  96. Evaluation of a new apolipoprotein(a) isoform-independent assay for serum Lipoprotein(a)
    Tom C. Dembinski, Pat Nixon, Garry X. Shen · 2000 · Molecular and Cellular Biochemistry
  97. Structural features of the kringle domain determine the intracellular degradation of under-γ-carboxylated prothrombin: Studies of chimeric rat/human prothrombin
    Wei Wu, John D. Bancroft, John W. Suttie · 1997 · Proceedings of the National Academy of Sciences
  98. Lipoprotein (a) induces angiogenesis on the chick embryo chorioallantoic membrane
    Ribatti, Ribatti, Vacca · 1998 · European Journal of Clinical Investigation
  99. Serum LP(a) levels in African Aboriginal Pygmies and Bantus, Compared with Caucasian and Asian Population samples
    Christa M. Cobbaert, Paul G.H. Mulder, Jan Willem Lindemans, Hugo Kesteloot · 1997 · Journal of Clinical Epidemiology
  100. Apoprotein (A) antagonises THE GPIIB/IIIA receptor on collagen and ADP-stimulated human platelets
    Edward Barre D. · 2004 · Frontiers in bioscience